Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections. - Wikidata - wikimedia - TriplyDB

Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections.

Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections.

http://www.wikidata.org/entity/Q40483507

about

Calcium Orthophosphate-Containing Biocomposites and Hybrid Biomaterials for Biomedical Applications The big picture on nanomedicine: the state of investigational and approved nanomedicine products Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitis Structure, Properties, and In Vitro Behavior of Heat-Treated Calcium Sulfate Scaffolds Fabricated by 3D Printing Biocomposites and hybrid biomaterials based on calcium orthophosphates Biocompatibility of artificial bone based on vancomycin loaded mesoporous silica nanoparticles and calcium sulfate composites First histological observations on the incorporation of a novel nanocrystalline hydroxyapatite paste OSTIM in human cancellous bone.Boosting effect of bisphosphonates on osteoconductive materials: a histologic in vivo evaluation.Evaluation of a novel nanocrystalline hydroxyapatite paste Ostim in comparison to Alpha-BSM - more bone ingrowth inside the implanted material with Ostim compared to Alpha BSM Facile synthesis of an up-conversion luminescent and mesoporous Gd2O3 : Er3+@nSiO2@mSiO2 nanocomposite as a drug carrier.pHEMA-nHA encapsulation and delivery of vancomycin and rhBMP-2 enhances its role as a bone graft substitute.Novel biocatalytic polymer-based antimicrobial coatings as potential ureteral biomaterial: preparation and in vitro performance evaluation.Nanobacteria: fact or fiction? Characteristics, detection, and medical importance of novel self-replicating, calcifying nanoparticles.Effects of apatite particle size in two apatite/collagen composites on the osteogenic differentiation profile of osteoblastic cells.Nanoparticulate drug delivery platforms for advancing bone infection therapies.Effect of hydroxyapatite nanoparticles on the growth and p53/c-Myc protein expression of implanted hepatic VX2 tumor in rabbits by intravenous injection.Heparinized nanohydroxyapatite/collagen granules for controlled release of vancomycin.The Role of Hydroxyl Channel in Defining Selected Physicochemical Peculiarities Exhibited by Hydroxyapatite.Biocompatibility evaluation of dicalcium phosphate/calcium sulfate/poly (amino acid) composite for orthopedic tissue engineering in vitro and in vivo.Physicochemical properties and cellular responses of strontium-doped gypsum biomaterials.Immobilized antibiotics to prevent orthopaedic implant infections.Combination therapy with vancomycin-loaded calcium sulfate and vancomycin-loaded PMMA in the treatment of chronic osteomyelitis.Comparison of Borate Bioactive Glass and Calcium Sulfate as Implants for the Local Delivery of Teicoplanin in the Treatment of Methicillin-Resistant Staphylococcus aureus-Induced Osteomyelitis in a Rabbit Model Evaluation of BSA protein release from hollow hydroxyapatite microspheres into PEG hydrogel.Acute intraoperative reactions during the injection of calcium sulfate bone cement for the treatment of unicameral bone cysts: a review of four cases Antibacterial surfaces for biomedical devices.Pathological calcification and replicating calcifying-nanoparticles: general approach and correlation.Biodegradable vs non-biodegradable antibiotic delivery devices in the treatment of osteomyelitis.Coatings and surface modifications imparting antimicrobial activity to orthopedic implants.Nanoparticulate platforms for targeting bone infections: meeting a major therapeutic challenge.Chlorhexidine-loaded hydroxyapatite microspheres as an antimicrobial delivery system and its effect on in vivo osteo-conductive properties.Calcium silicate-based cements and functional impacts of various constituents.Simultaneous bactericidal and osteogenic effect of nanoparticulate calcium phosphate powders loaded with clindamycin on osteoblasts infected with Staphylococcus aureus.In vitro/in vivo comparison of cefuroxime release from poly(ε-caprolactone)-calcium sulfate implants for osteomyelitis treatment.Assessment of cellular viability on calcium sulphate/hydroxyapatite injectable scaffolds.Nanocrystalline hydroxyapatite facilitates bone apposition to polymethylmethacrylate: histological investigation using a sheep model.Limitation of the antibiotic-eluting bone graft substitute: An example of gentamycin-impregnated calcium sulfate.A novel injectable borate bioactive glass cement as an antibiotic delivery vehicle for treating osteomyelitis Lecithin-based wet chemical precipitation of hydroxyapatite nanoparticles In vitro elution characteristics of gentamicin and vancomycin from synthetic bone graft substitutes.

P2860

Q26799302-3A00C730-A5E0-4B42-A2F8-4B81E5A46FCD Q27021817-27C0D5A3-08A5-439A-B481-4A4C980C56D1 Q28086953-ABA03A76-5CC6-481C-BF10-1F06BC9DEE4B Q28550912-B11270A7-D12D-4EF9-AA68-A70C13CEDF35 Q28709942-919756BD-29CD-450E-8CA6-8F3D38EA6DF4 Q30390210-F1596840-162D-4B64-98A3-E20DF0024BB9 Q33246176-A72E84C7-8D23-4FA2-B6EB-B0065D521DAA Q33274257-E01545D3-9A78-42C7-A226-69593F7B07D2 Q33520367-C138F68B-C807-42B1-95EC-DDDF42E34967 Q33754802-83E05D7B-D44A-4FC9-9784-1B987B08B059 Q34446441-3CB0C39A-5F13-4AAA-BA81-1A6343DAB441 Q34528925-B323A30D-1B91-4FE5-8959-7ADAC98F10B2 Q34591040-A3A53258-24BD-495B-9172-83DDB9C0F0E1 Q35010649-0D40B462-C322-416C-AEB8-1552898C26F6 Q35373671-1DC757F3-0F62-4F2F-B13E-2A0874F0BEC8 Q35397153-1CD40ECC-143C-4F58-AA0B-9659A8F18D5C Q35578972-AB099486-8B46-4663-B9BB-D9CAFE28A500 Q35897293-C533172D-5165-44BE-A3EB-2FE4C6B6BB1C Q36002442-52294508-23B5-41EF-862D-764E45DABBCA Q36032062-8A1582F3-A3C1-43B3-A525-C7E4A144EBF2 Q36146837-131A68B2-965D-4FB0-B6A7-9BB516BA68DD Q36231856-0704D268-EC86-4B74-A9CB-C776CC4E2780 Q36290681-D122FF47-3593-411A-88D1-7EF5E7303BF9 Q36701929-2801C6E7-E4BE-4BAE-932F-CB23F1B14E55 Q37016239-943D3094-2846-4292-BBA0-AF993E1FFCA8 Q37596429-540EC529-52F1-4A6D-ADC6-73DE5E9563FA Q37679688-976C61B2-C84B-4652-B4DC-569387EBC5D5 Q38071675-2505F3EE-1B85-46A0-938C-6BF1CF4BEC0C Q38215477-1FB6E4FC-13EC-4893-B8EC-C0DD2AD8254E Q38601755-50607A09-06BA-4656-AD22-B5EAD4C9A80C Q38897354-E9AAFEF5-829C-4029-96B9-4B6EE47D2023 Q38989036-663E10EB-64A7-42B0-B3BB-C12EDE2D5F3E Q39019951-720BB7AF-AE24-4234-89D3-B01BE7646AD2 Q39166353-10BAF379-B321-4FF0-9F9D-BEC223A8D10A Q39247591-797B79B8-4EBF-414B-ACA3-156DDF11CA4F Q39253329-2ACA5E85-2613-4369-AD5A-DD6390D8D036 Q40446308-9AD49D6C-E397-4EB6-825F-6513827430EE Q41865616-56546E8F-FC86-4179-A0B7-05517A616984 Q42047085-E404F9BB-55AD-4564-AF37-2B1C4FFDF51A Q42110110-A56C9C02-A5E2-4C1B-A773-3125E8DCA018

P2860

Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections.

http://www.wikidata.org/entity/Q40483507

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Nanocrystalline hydroxyapatite ...... ntibiotics in bone infections.

@en

type

label

Nanocrystalline hydroxyapatite ...... ntibiotics in bone infections.

@en

prefLabel

Nanocrystalline hydroxyapatite ...... ntibiotics in bone infections.

@en

P1433

Q40483507-138965FD-8611-4B3A-9BF6-0CF6B3CF44A4

P1476

Q40483507-F63A5C5B-2C14-4F14-A3AE-1EF13E221030

P2093

Q40483507-331A7323-5D18-482D-8C35-16ED6BCF0F1B

Q40483507-4F850471-A3A1-46B5-BD96-CBA3D1EDAC8B

Q40483507-63A03884-81DE-429E-8C5C-8A960CE12034

Q40483507-66ACD15A-5FDB-425D-8FB0-F2AE24015062

Q40483507-A50C4268-A14E-4B91-A7CE-66D012935C64

Q40483507-C55650F9-308F-4C0F-9EF7-997D5F179BD8

Q40483507-D6DD9B33-6A47-466C-BD9C-B04F43A871C8

P304

Q40483507-142AF1AB-F50B-468A-8269-485B1A2C2812

P31

Q40483507-E4A2DBC2-AE8B-4D52-9814-DBE0F5E94B69

P356

Q40483507-77E572B6-F7A3-47B6-82E2-53C79638220D

P433

Q40483507-D9872525-BD65-4BFC-B3AB-90AD7F71785D

P478

Q40483507-A8F2F976-A3E4-447E-A0BC-B7B325795FC9

P577

Q40483507-08880220-44F2-4467-AEC2-8B7119814C54

P698

Q40483507-043BE11A-3E74-4D9A-8F67-7F3D9B3D5D07

P921

Q40483507-5B26CECC-B137-4376-A911-4F8803C0D335

Q40483507-B93165F2-D049-4DC0-B52E-860EC24DF9A6

P356

J.BIOMATERIALS.2004.06.045

P1433

P1476

Nanocrystalline hydroxyapatite ...... ntibiotics in bone infections.

@en

P2093

Elvira Dingeldein

http://www.w3.org/2001/XMLSchema#string

Ludwig Zichner

http://www.w3.org/2001/XMLSchema#string

Michael A Rauschmann

http://www.w3.org/2001/XMLSchema#string

Reinhard Schnettler

http://www.w3.org/2001/XMLSchema#string

Thomas A Wichelhaus

http://www.w3.org/2001/XMLSchema#string

Volker Alt

http://www.w3.org/2001/XMLSchema#string

Volker Stirnal

http://www.w3.org/2001/XMLSchema#string

P304

2677-2684

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOMATERIALS.2004.06.045

http://www.w3.org/2001/XMLSchema#string

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15585271

http://www.w3.org/2001/XMLSchema#string

P921